Ovarian cancer immuno-reactive antigen domain containing 1 (OCIAD 1), a key player in ovarian cancer cell adhesion

被引:21
作者
Sengupta, Saubhik [1 ]
Michener, Chad M. [1 ]
Escobar, Pedro [1 ,2 ]
Belinson, Jerome [1 ]
Ganapathi, Ram [3 ]
机构
[1] Cleveland Clin, Gynecol Oncol Sect, Dept Obstet & Gynecol, Cleveland, OH 44195 USA
[2] Lee Canc Care, Ft Myers, FL 33901 USA
[3] Cleveland Clin, Taussig Canc Ctr, Dept Expt Therapeut, Cleveland, OH 44195 USA
关键词
ovarian cancer; metastasis; cell adhesion; OCIAD1; LPA;
D O I
10.1016/j.ygyno.2007.12.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. To identify proteins unique to metastatic ovarian cancer and test their potential involvement in cell adhesion. Methods. We purified plasma membrane from paired metastatic and primary tumor tissues from patients with stage IIIC ovarian cancer. Membrane proteins unique to metastases were identified by liquid chromatographic mass spectrometry (LC-MS). The role of one of the identified proteins, ovarian cancer immuno-reactive antigen domain containing 1 (OCLAD 1) in cell adhesion was determined in the presence of LPA using both over-expression and down regulation approaches. Results. We identified a differentially expressed 29 kDa protein as OCIAD1 over-expressed in metastatic tissues, when compared to primary tumor tissues. OCIAD1 over-expression in HEY ovarian cancer cells increased LPA-induced, but not basal level cell adhesion to extracellular matrix proteins collagen I and laminin 10/11. This enhancement was not blocked by LY294002 and GF 109203X, suggesting that OCIAD1 does not use PKC and PI3K signaling pathways to exert its effect on adhesion. In addition, LPA induced cell adhesion to collagen I was unaffected by paclitaxel (5 mu M) in OCIAD1 overexpressing cells. Conclusions. This is the first report that OCIAD1 is over-expressed in metastatic ovarian cancer tissues. The effect of OCIAD1 on cell adhesion may be related to its function in ovarian cancer. Failure of paclitaxel to affect ovarian cancer cell adhesion in presence of OCIAD1 raises the possibility of OCIAD1's role in tumor metastasis. Ongoing studies using a mouse orthotopic LPA-dependent ovarian cancer metastasis model are focused on strategies to inhibit the potential role of OCIAD1 in tumor metastasis. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:226 / 233
页数:8
相关论文
共 27 条
  • [1] Amadori D., 1997, Frontiers in Bioscience (online), V2, pG8
  • [2] Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
    Bapat, SA
    Mali, AM
    Koppikar, CB
    Kurrey, NK
    [J]. CANCER RESEARCH, 2005, 65 (08) : 3025 - 3029
  • [3] Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific
    Baudhuin, LM
    Cristina, KL
    Lu, J
    Xu, Y
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (03) : 660 - 671
  • [4] Lysophosphatidic acid receptors
    Contos, JJA
    Ishii, I
    Chun, J
    [J]. MOLECULAR PHARMACOLOGY, 2000, 58 (06) : 1188 - 1196
  • [5] Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling
    Davidson, B
    Espina, V
    Steinberg, SM
    Florenes, VA
    Liotta, LA
    Kristensen, GB
    Tropé, CG
    Berner, A
    Kohn, EC
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (03) : 791 - 799
  • [6] Annual report to the Nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment
    Edwards, BK
    Brown, ML
    Wingo, PA
    Howe, HL
    Ward, E
    Ries, LAG
    Schrag, D
    Jamison, PM
    Jemal, A
    Wu, XC
    Friedman, C
    Harlan, L
    Warren, J
    Anderson, RN
    Pickle, LW
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (19): : 1407 - 1427
  • [7] Lysophosphatidic acid is a bioactive mediator in ovarian cancer
    Fang, XJ
    Schummer, M
    Mao, ML
    Yu, SX
    Tabassam, FH
    Swaby, R
    Hasegawa, Y
    Tanyi, JL
    LaPushin, R
    Eder, A
    Jaffe, R
    Erickson, J
    Mills, GB
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1582 (1-3): : 257 - 264
  • [8] Fishman DA, 2001, CANCER RES, V61, P3194
  • [9] The LPA receptors
    Fukushima, N
    Chun, J
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2001, 64 (1-4): : 21 - 32
  • [10] HE L, 2000, CLIN CANCER RES, V6, P880